Allianz Asset Management’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Allianz Asset Management’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-363,381	Closed	-$3.26M	–	2780
2016 Q3	$3.26M	Buy	363,381 +3,009	+0.8%	+$21.4K	﹤0.01%	1794
2016 Q2	$1.94M	Buy	+360,372	New	+$1.85M	﹤0.01%	1929
2015 Q2	–	Sell	-100,905	Closed	-$1.1M	–	2641
2015 Q1	$1.1M	Sell	100,905 -19,181	-16%	-$196K	﹤0.01%	1754
2014 Q4	$1.26M	Sell	120,086 -956	-0.8%	-$9.34K	﹤0.01%	1745
2014 Q3	$1.16M	Sell	121,042 -6,006	-5%	-$61.3K	﹤0.01%	1621
2014 Q2	$1.47M	Buy	127,048 +28,379	+29%	+$258K	﹤0.01%	1294
2014 Q1	$987K	Sell	98,669 -5,972	-6%	-$86.2K	﹤0.01%	1409
2013 Q4	$1.36M	Sell	104,641 -6,166	-6%	-$84.9K	﹤0.01%	1318
2013 Q3	$1.66M	Buy	+110,807	New	+$1.33M	﹤0.01%	1239

Allianz Asset Management's RPTP Position: Q4 2016 in Review

Allianz Asset Management sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 363,381 shares — an estimated $3.26M sold.

Allianz Asset Management first reported a position in RPTP in Q3 2013 and held it in 9 quarters. The position peaked at $3.26M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

Allianz Asset Management reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
Allianz Asset Management sold 363,381 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $3.26M.
Allianz Asset Management first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2013 and held it in 9 quarters.
Allianz Asset Management's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $3.26M in Q3 2016.
0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.